The store will not work correctly when cookies are disabled.
N-(2-chloro-5-(trifluoromethyl)phenyl)quinoxaline-6-carboxamide
ID: ALA1278216
Cas Number: 720677-78-1
PubChem CID: 1034352
Max Phase: Preclinical
Molecular Formula: C16H9ClF3N3O
Molecular Weight: 351.71
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1cc(C(F)(F)F)ccc1Cl)c1ccc2nccnc2c1
Standard InChI: InChI=1S/C16H9ClF3N3O/c17-11-3-2-10(16(18,19)20)8-13(11)23-15(24)9-1-4-12-14(7-9)22-6-5-21-12/h1-8H,(H,23,24)
Standard InChI Key: BPRRNZUKKIBQRK-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
1.7236 -10.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7224 -11.1773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4372 -11.5902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1537 -11.1769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1508 -10.3463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4354 -9.9372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4330 -9.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8688 -11.5882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5826 -11.1746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2977 -11.5860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5813 -10.3496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2943 -12.4094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0086 -12.8207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0046 -11.1702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7195 -11.5778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7224 -12.4065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4404 -12.8165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1560 -12.3990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1490 -11.5671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4304 -11.1608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4370 -12.4152 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.1462 -8.6976 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.7173 -8.7018 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.2171 -8.3159 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10 12 2 0
6 1 1 0
12 13 1 0
13 16 2 0
1 2 2 0
15 14 2 0
14 10 1 0
6 7 1 0
3 4 2 0
15 16 1 0
4 8 1 0
16 17 1 0
17 18 2 0
8 9 1 0
18 19 1 0
4 5 1 0
19 20 2 0
20 15 1 0
9 10 1 0
3 21 1 0
2 3 1 0
7 22 1 0
9 11 2 0
7 23 1 0
5 6 2 0
7 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 351.71 | Molecular Weight (Monoisotopic): 351.0386 | AlogP: 4.55 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.77 | CX Basic pKa: 1.06 | CX LogP: 3.87 | CX LogD: 3.87 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.74 | Np Likeness Score: -2.05 |
References
1. Carosati E, Sforna G, Pippi M, Marverti G, Ligabue A, Guerrieri D, Piras S, Guaitoli G, Luciani R, Costi MP, Cruciani G.. (2010) Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors., 18 (22): [PMID:20951595] [10.1016/j.bmc.2010.09.065] |